Clinical Trial Update: Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating infliximab for prevention of recurrent Crohn's disease after surgical resection; the study is completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: University of Pittsburgh | Conditions: Crohn's Disease | Phase 4 | Status: COMPLETED | Results posted: 2016-09-26